2000-09-13
Adverse cardiovascular effects of drugs in patients with heart failure: Pharmaco-epidemioiogicai studies on ibopamine and NSAIDs
Publication
Publication
Cardiovasculaire bijwerkingen van geneesmiddelen bij patient en met hartfalen: Farmaco-epidemiologische studies betreffende NSAIDs en ibopamine
Heart failure is one of the most common cardiovascular disorders in westem countries. Because (congestive) heart failure is a chronic, incapacitating disease with a poor prognosis and a substantial public health impact, the attention paid to this disorder in research and both scientific as well as popular publications is fully justified. In addition, the incidence and prevalence of heart failure tend to increase, in particular because of ageing of the population and increased survival after acute myocardial infarction.
| Additional Metadata | |
|---|---|
| , , , , | |
| Netherlands Ministry of Health, NWO, Netherlands Heart Foundation, Dutch trombose Foundation, Rotterdam Medical Research Foundation, Topcon Europe BV,Rotterdamse Vereniging voorr Blindenbelangen, Stichting Bevordering voor Volkskracht, Stichting Fondsenwerving Acties Volksgezondheid, EMC Rotterdam, Utrecht Medical Center, AstraZeneca BV, Christiaens BV, Searle, Yamanouchi Pharma BV | |
| D.E. Grobbee (Diederick) | |
| Erasmus University Rotterdam | |
| hdl.handle.net/1765/20460 | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
Feenstra, J. (2000, September 13). Adverse cardiovascular effects of drugs in patients with heart failure: Pharmaco-epidemioiogicai studies on ibopamine and NSAIDs. Retrieved from http://hdl.handle.net/1765/20460 |
|
